Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
forgiftning med quinolin OG/ELLER hydroxyquinolinderivat |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Hydroxyquinoline poisoning |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Accidental hydroxyquinoline poisoning |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Intentional hydroxyquinoline poisoning |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
forgiftning med hydroxyquinolin, uvist med hvilken hensigt |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Accidental diiodohydroxyquinoline poisoning |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Intentional diiodohydroxyquinoline poisoning |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
forgiftning med diiodohydroxyquinolin, uvist med hvilken hensigt |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Poisoning by diiodohydroxyquin |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Quinoline or hydroxyquinoline poisoning NOS |
Causative agent |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing clioquinol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
hydroxyquinolinantiprotozomiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
clioquinol 3 % + hydrocortison 0,5 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol+hydrocortisone 3%/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol+hydrocortisone 3%/1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
clioquinol + hydrocortison + pramoxinhydrochlorid 3 % wt/wt/1 % wt/wt/0,5 % wt/wt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
clioquinol 3 % wt/wt + hydrocortison 0,5 % wt/wt creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
clioquinol + hydrocortison 3 % wt/wt/0,5 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Clioquinol+flumethasone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing ascorbic acid and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing benzoyl peroxide and potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
clioquinol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
benzoylperoxid + kaliumhydroxyquinolinsulfat 5/0,5 % gel-lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
Product containing potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
fluocinolonacetonid 0,025 % + clioquinol 3 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|
fluocinolonacetonid 0,025 % + clioquinol 3 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Quinoline and hydroxyquinoline - chemical |
Inferred relationship |
Some |
|